Long-term outcomes following antenatal exposure to low-dose aspirin: study protocol for the 4-year follow-up of the APRIL randomised controlled trial.
Anadeijda J E M C LandmanEmilie V J van Limburg StirumJanneke van 't HooftAleid G LeemhuisMartijn J J FinkenAnneloes L van BaarTessa J RoseboomAnita C J RavelliMadelon van WelyJaap OosterlaanRebecca C PainterEva PajkrtMartijn A OudijkMarjon A de BoerPublished in: BMJ open (2022)
The APRIL trial (NTR5675, NL5553; EudraCT number 2015-003220-31) and the APRIL follow-up study (NL8950) are registered in the Dutch trial register. The study is funded by the Amsterdam Reproduction & Development research institute.